title: Area postrema removal abolishes stimulatory effects of intravenous interleukin-1beta on hypothalamic-pituitary-adrenal axis activity and c-fos mRNA in the hypothalamic paraventricular nucleus.
abstract: This study examined the role of the area postrema (AP) in transducing peripheral immune signals, represented by intravenous (i.v.) interleukin-1beta (IL-1), into neuroendocrine responses. The AP, a circumventricular organ with a leaky blood-brain barrier, lies adjacent to the nucleus of the solitary tract (NTS) in the medulla. The AP was removed by aspiration, and 2 weeks later, AP-lesioned or sham-lesioned rats were injected i.v. with 0.5 microg/kg IL-1 or sterile saline. After 30 min, brains were removed and analyzed for c-fos mRNA levels in various structures implicated in the hypothalamic-pituitary-adrenal axis response to peripheral cytokine challenge. The sham-lesioned animals responded to IL-1 with large elevations in adrenocorticotropic hormone (ACTH) and corticosterone levels in the plasma and c-fos mRNA levels in cells of the AP, NTS, central nucleus of the amygdala, bed nucleus of the stria terminalis, hypothalamic paraventricular nucleus (PVN), and meninges. Prior AP removal abolished the IL-1 -induced increases in ACTH and corticosterone in the plasma and c-fos mRNA levels in the NTS and PVN. However, AP removal had no effect on IL-1-induced increases in c-fos mRNA levels in the other areas examined. The selective AP lesion effects suggest that the AP and adjacent NTS play a pivotal role in transducing a circulating IL-1 signal into hypothalamic-pituitary-adrenal axis activation by a pathway that may be comprised of known anatomical links between the AP, NTS, and corticotropin-releasing hormone neurons of the PVN.
authors.affiliation: Section on Functional Neuroanatomy, NIMH, Bethesda, MD 20892-4070, USA.
authors.forename: H Y
authors.initials: HY
authors.lastname: Lee
authors.forename: M B
authors.initials: MB
authors.lastname: Whiteside
authors.forename: M
authors.initials: M
authors.lastname: Herkenham
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000679:Amygdala / Q000737:chemistry; D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects; D002552:Cerebral Ventricles / Q000098:blood supply / Q000601:surgery; D003345:Corticosterone / Q000378:metabolism; D015870:Gene Expression / Q000502:physiology; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects / Q000502:physiology*; D017403:In Situ Hybridization; D007275:Injections, Intravenous; D007375:Interleukin-1 / Q000494:pharmacology* / Q000502:physiology; D008297:Male; D010286:Paraventricular Hypothalamic Nucleus / Q000737:chemistry* / Q000502:physiology; D010913:Pituitary-Adrenal System / Q000187:drug effects / Q000502:physiology*; D016760:Proto-Oncogene Proteins c-fos / Q000235:genetics*; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D012686:Septal Nuclei / Q000737:chemistry; D015398:Signal Transduction / Q000502:physiology; D017552:Solitary Nucleus / Q000502:physiology
chemical_list: D007375:Interleukin-1; D016760:Proto-Oncogene Proteins c-fos; D012333:RNA, Messenger; D000324:Adrenocorticotropic Hormone; D003345:Corticosterone